Technology

AI turns its sights to drug discovery challenges

AI turns its sights to drug discovery challenges

The WHO states that cancer is a “leading cause of death worldwide”. It accounted for nearly 1 in 6 deaths in 2020; that’s almost 10 million. Each year millions of pounds are pumped into cancer research across the world, yet deaths are likely to increase over the next...

“Shot to the heart” (of mutating viruses)

“Shot to the heart” (of mutating viruses)

As the Covid-19 pandemic continues with myriad variants, current vaccine technology is struggling to keep up. Often employing B-cell immune responses, vaccines are unable to “anticipate virus mutations”, rendering the patient “vulnerable to infection”. According to...

Twist Bioscience turns to monkeypox controls

Twist Bioscience turns to monkeypox controls

Twist Bioscience has launched two monkeypox synthetic DNA controls that are estimated to provide 80% coverage of the viral genome. They support the design of “custom assays targeting regions of the genome”. They can also be used for “amplicon and capture-based...

Prioritising pathogens in a pandemic world

Prioritising pathogens in a pandemic world

The WHO list of priority diseases sets out the diseases and pathogens that research and development in “public health emergency contexts” should address. The aim is “focused and productive” research and development. These diseases are evaluated on their epidemic...

Solving supply chain safety and sustainability concerns

Solving supply chain safety and sustainability concerns

Through healthcare crisis after healthcare crisis the need for safe and sustainable supply chains is more pressing than ever. Increasing need for cold-chain products requires innovative solutions and recent regulatory changes emphasise this requirement, hence Johnson...

Demanding sustainable subscriptions for AMR

Demanding sustainable subscriptions for AMR

Drs Till Boularte and Ulrik Schilze of BCG stated in February 2022 that “when market forces fail to motivate adequate innovation, other incentives are necessary”. In our article on AMR we explored the risks involved in a highly volatile and expensive market. Shelley...

Operation Warp Speed is a wrap: farewell to funding

Operation Warp Speed is a wrap: farewell to funding

In typical American fashion the US Covid-19 vaccination development programme took the name “Operation Warp Speed” (OWS). OWS invested approximately $18 billion in clinical development and manufacturing of covid vaccines, with agreements to purchase 455 million doses....